Davide Dalle

I,Davide Dalle Fusine, nominated byItaly, residing inShanghai,China, a member of the Medical and Chemicals Technical Options Committee declare as follows.

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I amGeneral Manager and Legal Representative at Chiesi Pharmaceutical Shanghai Co. Ltd.and my responsibilities include the management of all the activities of Chiesi Farmaceutici S.p.A. in People Republic of China.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents, include the following:

1. Proprietary interests: I do not have proprietary interest in a substance, technology or process to be considered by TEAP or any of its TOCs or temporary subsidiary bodies (e.g. task forces).
2. Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
3. Employment, consultancy, directorship or other positions: I have an interest in the topics of Montreal Protocol based on the fact that, as employee of Chiesi Group, I am engaged in the development and commercialization of pMDI and DPI products.
4. Government advice and other policy development: I do not provide any advice to any governmental authority.
5. Paid research activities, fellowships or grants: I have not any other relationship than the labor relationship with Chiesi Farmaceutici SpA.
6. Other interests: None.

5. The source of funding for my participation in the work of the Medical and Chemicals Technical Options Committee isChiesi Pharmaceutical Shanghai Co. Ltd.
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have declined to disclose information falling within paragraph 10 of those Guidelines and I undertake to ensure that I am completely excluded from discussion and decisions on topics related to the information that I have declined to disclose.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the Medical and Chemicals Technical Options Committee.
9. I understand that this DOI will expire no later than one year after I have signed it.

Name: Davide Dalle Fusine

Date: February 1st 2018